✦ LIBER ✦

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

✍ Scribed by Richard B Lipton; David W Dodick; Stephen D Silberstein; Joel R Saper; Sheena K Aurora; Starr H Pearlman; Robert E Fischell; Patricia L Ruppel; Peter J Goadsby

Book ID: 114409468
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 117 KB
Volume: 9
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70054-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot double-blind sham-controlled tri

A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine

✍ Danilo Rocha de Jesus; Alexei Gil; Leonardo Barbosa; Maria Inês Lobato; Pedro Vi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Effect of High- and Low-Frequency Repeti

Effect of High- and Low-Frequency Repetitive Transcranial Magnetic Stimulation on Visuospatial Neglect in Patients With Acute Stroke: A Double-Blind, Sham-Controlled Trial

✍ Kim, Bo Ryun; Chun, Min Ho; Kim, Dae-Yul; Lee, Sook Joung 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 140 KB

P.4.e.001 Low frequency repetitive trans

P.4.e.001 Low frequency repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study

✍ J.M. Song; C.U. Pae; Y.J. Lee; W.M. Bahk; T.Y. Jun; W. Hahm; J.H. Chae 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Results of a multicenter, double-blind,

Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine

✍ Goldstein, J.; Hagen, M.; Gold, M. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

NeuroThera®Efficacy and Safety Trial – 3

NeuroThera®Efficacy and Safety Trial – 3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera®Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset

✍ J. A. Zivin; R. Sehra; A. Shoshoo; G. W. Albers; N. M. Bornstein; B. Dahlof; S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB